About this trial
This is a a type 3 hybrid effectiveness-implementation pilot study to evaluate the PRONTO-EYE intervention, a rideshare transportation program, in patients with diabetic retinopathy with Medicaid insurance on adherence to ophthalmology visits.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Established patient
Medicaid insurance
History of diabetic retinopathy
Lives within 25 miles of the clinic
Disqualifiers
None
Trial design
Single group
Treatments tested in this trial
PRONTO-EYE
BehavioralThe PROgram for Non-emergency TranspOrtation (PRONTO) - EYE intervention is a rideshare transportation program designed for patients to get to and from their visits. The intervention includes the rideshare as well as a service blueprint of the offering and how all individuals in the health system interact with it.
Treatment groups
Trial outcomes
Primary outcomes
Number of patients that adhere to their scheduled ophthalmology visits
Proportion of patients who attend their scheduled ophthalmology visit compared to pre-implementation historical controls.
Secondary outcomes
Adoption of PRONTO-EYE
Uptake and intention to employ the innovation, including percentage of patients who opt into rideshare and stakeholder buy-in, assessed via EHR data and interviews.
Appropriateness of PRONTO-EYE
Perceived fit, relevance, or compatibility of the intervention for the clinic's mission and patient needs, measured using questions adapted from the Intervention Appropriateness Measure (IAM) survey and interviews.
Feasibility of PRONTO-EYE
The number of rides successfully completed divided by the number of rides scheduled, as assessed via ride logs and observation.
Fidelity of PRONTO-EYE
Degree to which the PRONTO-EYE transportation intervention was implemented as originally proposed, including adherence to planned processes for ride scheduling, patient eligibility criteria, and staff roles. Assessed via EHR data, program logs, and semi-structured interviews with staff.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Illinois at Chicago
Lead sponsor
National Eye Institute (NEI)
Collaborator